Dr. Elizabeth Verduzco, DO

Dr. Verduzco practices at Hoboken University Hospital in Hoboken, New Jersey, part of Hudson Regional Health.

Dr. Verduzco's NPI, 1669734117, was assigned on June 11, 2012. Dr. Verduzco graduated from Des Moines University College of Osteopathic Medicine in 2012. Dr. Verduzco holds New Jersey license 25MB09611700.

Dr. Verduzco's primary practice is Hoboken University Hospital, at 308 Willow Ave, Hoboken, NJ 07030 in Hudson County. The practice phone is (201) 418-1000.

Dr. Verduzco's primary practice is Hoboken University Hospital in Hoboken, New Jersey, part of Hudson Regional Health. Dr. Verduzco is also affiliated with Richmond University Medical Center. The medical group on file is CarePoint Health Medical Group. Dmand AI also links Dr. Verduzco to 2 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Verduzco practices, 6 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Verduzco's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dmand AI has Dr. Verduzco's licenses on file in 2 states: New Jersey and New York.

CMS data shows 443 Medicare services from Dr. Verduzco across 3 procedure codes in 2024, for 314 Medicare patients. Medicare paid $45,329 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 314 Medicare patients who saw Dr. Verduzco in 2024. The largest group is 85 and over, with 120 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 55% are also on Medicaid. Their average risk score is 2.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Verduzco's median patient age at 70, with 50% women.

In 2024, Dr. Verduzco wrote 25 Medicare Part D claims for 16 patients. 100% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $43 in total drug cost. In 2023, CMS named 25 claims across 2 drugs.

Dr. Verduzco accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 27 procedures of removal of tissue by Dr. Verduzco, more than 72% of the clinicians it reports for that procedure.

Hernia repair (minimally invasive): 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 76 general payments to Dr. Verduzco from 20 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 59% of the total. Davol Inc. paid the most, $3,293.

Dr. Verduzco graduated from Des Moines University College of Osteopathic Medicine in 2012.